In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study

被引：0
|
作者：
F Bonifazi
G Bandini
M Stanzani
F Palandri
B Giannini
M Arpinati
G Rosti
M Baccarani
机构：
[1] University of Bologna,Institute of Hematology ‘L. and A. Seràgnoli’
[2] S Orsola-Malpighi Hospital,undefined
来源：
Bone Marrow Transplantation | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1025 / 1026
页数：1
相关论文
共 50 条
  • [21] Peripheral blood stem cell RIC haploidentical stem cell transplantation low TRM, low rates of GVHD: Preliminary results from the prospective Phase II single arm UK Haplo study (Bloodwise: 11034)
    Raj, K.
    Protheroe, R.
    Smith, M.
    Gilleece, M.
    Snowden, J.
    Uttenthal, B.
    Irvine, D.
    Collin, M.
    Paneesha, S.
    Salim, R.
    Tholouli, E.
    Marwood, E.
    Mesiri, P.
    Timur, H.
    O'Connor, C.
    Clifton-Hadley, L.
    Marks, D.
    Mackinnon, S.
    Pagliuca, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 13 - 13
  • [22] In vivo T cell depletion with low-dose rabbit antithymocyte globulin results in low transplant-related mortality and low relapse incidence following unrelated hematopoietic stem cell transplantation
    Nachbaur, D
    Eibl, B
    Kropshofer, G
    Meister, B
    Mitterschiffthaler, A
    Schennach, H
    Fischer, G
    Kopp, M
    Gunsilius, E
    Gastl, G
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2002, 11 (04): : 731 - 737
  • [23] Ex-vivo T-cell depleted peripheral blood stem cell transplantation from HLA-matched sibling donors for the treatment of severe aplastic anemia
    Cano-Ferri, I.
    Moscardo, F.
    Sanz, J.
    Dasi, M. A.
    Solves, P.
    Lorenzo, I.
    Senent, L.
    Montesinos, P.
    Lopez-Chulia, F.
    Lancharro, A.
    Martinez, J.
    Carpio, N.
    Rodriguez-Veiga, R.
    Sanz, M. A.
    Sanz, G.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S274 - S274
  • [24] Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma.: A phase I/II study of the German Study-group Multiple Myeloma (DSMM)
    Kröger, N
    Einsele, H
    Wolff, D
    Casper, J
    Freund, M
    Derigs, G
    Wandt, H
    Schäfer-Eckart, K
    Wittkowsky, G
    Schmitz, N
    Krüger, W
    Zabelina, T
    Renges, H
    Ayuk, F
    Krüll, A
    Zander, A
    BONE MARROW TRANSPLANTATION, 2003, 31 (11) : 973 - 979
  • [25] Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM)
    Nicolaus Kröger
    Hermann Einsele
    Daniel Wolff
    Jochen Casper
    Mathias Freund
    Günter Derigs
    Hannes Wandt
    K Schäfer-Eckart
    Georg Wittkowsky
    Norbert Schmitz
    William Krüger
    Tatjana Zabelina
    Helmut Renges
    Francis Ayuk
    Andreas Krüll
    Axel Zander
    Bone Marrow Transplantation, 2003, 31 : 973 - 979
  • [26] T-Cell Replete Peripheral Blood Stem Cell Transplantation after Non-Myeloablative Conditioning with Post-Transplant High Dose Cyclophosphamide Is Safe and Is Associated with Acceptable Outcomes
    Bhamidipati, Pavan Kumar
    DiPersio, John F.
    Stockerl-Goldstein, Keith
    Uy, Geoffrey L.
    Westervelt, Peter
    Gao, Feng
    Vij, Ravi
    Schroeder, Mark A.
    Abboud, Camille
    Pusic, Iskra
    Romee, Rizwan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S29 - S30
  • [27] Low-Dose Decitabine Monotherapy Reverses Mixed Chimerism in Adult Patients After Allogeneic Hematopoietic Stem Cell Transplantation With Myeloablative Conditioning Regimen: A Pilot Phase II Study
    Wang, Ling
    Wang, Li-ning
    Zhou, Ji-fang
    Gao, Wen-hui
    Jiang, Chuan-he
    Tang, Wei
    Zhao, Wei-li
    Hu, Jiong
    Jiang, Jie-ling
    FRONTIERS IN MEDICINE, 2021, 8
  • [28] In vivo T-cell depletion with antithymocyte globulin or alemtuzumab for unrelated donor stem cell transplantation with reduced intensity conditioning: results of a multicentre randomized phase II clinical trial (the Global study) from the GITMO
    Algarotti, A.
    Mico, C.
    Corradini, P.
    Falda, M.
    Alessandrino, E. P.
    Fanin, R.
    Tagliaferri, E.
    Castagna, L.
    Mordini, N.
    Sica, S.
    Santarone, S.
    Levis, A.
    Iori, A.
    Pollichieni, S.
    Sacchi, N.
    Scarano, M.
    Masciulli, A.
    Marchioli, R.
    Bacigalupo, A.
    Bosi, A.
    Rambaldi, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S60 - S61
  • [29] Reconstitution of T cell subsets and its clinical significance after related HLA-haploidentical high-dose peripheral blood hematopoietic stem cell transplantation without T-cell depletion in vitro
    Pang, N.
    Jiang, M.
    Qu, J.
    Duan, X.
    Yuan, H.
    Guo, X.
    Xu, J.
    Cao, H.
    Chen, G.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S382 - S383
  • [30] Low-dose total skin electron beam therapy as a debulking agent for cutaneous T-cell lymphoma: an open-label prospective phase II study
    Kamstrup, M. R.
    Lindahl, L. M.
    Gniadecki, R.
    Iversen, L.
    Skov, L.
    Petersen, P. M.
    Loft, A.
    Specht, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (02) : 399 - 404
12345